Bath & Body Works (NYSE:BBWI) Issues Q3 2026 Earnings Guidance

Bath & Body Works (NYSE:BBWIGet Free Report) issued an update on its third quarter 2026 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 0.070-0.120 for the period, compared to the consensus earnings per share estimate of 0.270. The company issued revenue guidance of $1.6 billion-$1.7 billion, compared to the consensus revenue estimate of $1.6 billion. Bath & Body Works also updated its FY 2026 guidance to 2.600-2.800 EPS.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on the stock. Citigroup raised shares of Bath & Body Works from a “neutral” rating to a “buy” rating and set a $25.00 price target for the company in a report on Tuesday, August 18th. Raymond James Financial reaffirmed a “market perform” rating on shares of Bath & Body Works in a report on Wednesday, May 27th. Jefferies Financial Group boosted their target price on Bath & Body Works from $22.00 to $23.00 and gave the stock a “hold” rating in a research report on Tuesday, July 28th. TD Cowen increased their target price on Bath & Body Works from $20.00 to $25.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. Finally, Morgan Stanley reissued an “equal weight” rating and issued a $22.00 price target on shares of Bath & Body Works in a report on Monday, July 6th. Four investment analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $22.57.

Check Out Our Latest Research Report on Bath & Body Works

Bath & Body Works Stock Performance

Shares of BBWI stock opened at $17.58 on Wednesday. The stock has a fifty day moving average price of $20.39 and a 200 day moving average price of $20.03. The stock has a market cap of $3.54 billion, a PE ratio of 4.94, a P/E/G ratio of 1.89 and a beta of 1.38. Bath & Body Works has a 1 year low of $14.27 and a 1 year high of $32.32.

Bath & Body Works (NYSE:BBWIGet Free Report) last announced its quarterly earnings results on Wednesday, May 27th. The company reported $0.32 earnings per share for the quarter, beating analysts’ consensus estimates of $0.29 by $0.03. The business had revenue of $1.38 billion during the quarter, compared to analysts’ expectations of $1.36 billion. Bath & Body Works had a negative return on equity of 45.34% and a net margin of 10.03%.The business’s revenue for the quarter was down 3.2% on a year-over-year basis. During the same quarter last year, the business posted $0.49 earnings per share. As a group, equities research analysts predict that Bath & Body Works will post 2.63 earnings per share for the current year.

Bath & Body Works Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 4th. Shareholders of record on Friday, August 21st will be issued a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 4.6%. The ex-dividend date is Friday, August 21st. Bath & Body Works’s dividend payout ratio (DPR) is 22.47%.

Institutional Trading of Bath & Body Works

Several institutional investors and hedge funds have recently modified their holdings of the business. Sivia Capital Partners LLC purchased a new position in shares of Bath & Body Works in the 2nd quarter worth about $306,000. Atlas Capital Advisors Inc. purchased a new position in shares of Bath & Body Works in the fourth quarter valued at $156,000. Stifel Financial Corp acquired a new stake in shares of Bath & Body Works during the fourth quarter valued at about $209,000. Quadrant Capital Group LLC lifted its stake in shares of Bath & Body Works by 179.5% in the fourth quarter. Quadrant Capital Group LLC now owns 3,633 shares of the company’s stock worth $73,000 after acquiring an additional 2,333 shares in the last quarter. Finally, Commonwealth Equity Services LLC acquired a new stake in Bath & Body Works during the 4th quarter valued at approximately $211,000. Hedge funds and other institutional investors own 95.14% of the company’s stock.

Bath & Body Works Company Profile

(Get Free Report)

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.

Recommended Stories

Earnings History and Estimates for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.